Publication | Closed Access

Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954

Diabetes DevelopmentSignal TransductionRetinaOphthalmologyOcular DiseaseMedicinePhotoreceptor CellDiabetesPharmacologyOptogeneticsCell SignalingInsulin Signaling